Changes in Clinical Measures among US Adults with Type 2 Diabetes and Chronic Kidney Disease Receiving Once-Weekly Semaglutide vs. Oral Antidiabetic Medications
Authors:
James Amamoo1; Yan Wang2; Hongjiao Liu2; Manasvi Sundar2; Yan Song3; Lin Xie1; Sherif Mehanna1; Josh Noone1; Caroline Swift1; Matthew Weir4
Affiliations
View DetailsHide Details
Download poster (.pdf)
Share
Copy link
{{pageUrl}}
Keywords
Diabetes
Chronic Kidney Disease
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR
Get notified when materials for ADA 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
Get notified when materials for ADA 2025 and future congresses become available:
Slide decks
Posters
Videos ... and more.
{{ error.$message }}
Success
We will notify you when new materials become available for ADA 2025 and future congresses.
We will keep you updated in your inbox:
Subscribe to receive updates on related congresses in the same disease area: